Green Nuclear Medicine and Radiotheranostics

Area of Science:

• Nuclear medicine
• Environmental science
• Radiopharmaceutical production

Background:

• Increasing demand for diagnostic and therapeutic radiopharmaceuticals.
• Anticipated rise in nuclear medicine therapies necessitates environmental impact assessment.
• Current practices may not account for the full environmental footprint.

Purpose of the Study:

• To identify environmental impacts associated with radiopharmaceutical production and use.
• To propose mitigation measures for reducing the environmental footprint of nuclear medicine.
• To foster discussion within the nuclear medicine community regarding sustainability.

Main Methods:

• Review of the radiopharmaceutical supply chain, from isotope production to waste handling.
• Analysis of energy consumption and transportation logistics.
• Comparison of local versus centralized production models.
• Evaluation of radiopharmaceutical procedures against other medical imaging tests.

Main Results:

• Identified key impact areas including isotope production, energy supply, transportation, and waste management.
• Discussed potential environmental benefits and drawbacks of different production and usage strategies.
• Highlighted the need for adaptation of injected radiopharmaceutical amounts in clinical settings.

Conclusions:

• The expansion of nuclear medicine therapies requires proactive environmental management.
• Implementation of sustainable measures across the supply chain is crucial.
• Increased awareness and discussion are needed to minimize the environmental impact of radiopharmaceuticals.